表紙
市場調查報告書

微射流 (微流體)的全球市場:分析與預測 (2019-2029年)

Global Microfluidics Market: Focus on Application, Type, End User, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029

出版商 BIS Research Inc. 商品編碼 920200
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
微射流 (微流體)的全球市場:分析與預測 (2019-2029年) Global Microfluidics Market: Focus on Application, Type, End User, Country Data (15 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029
出版日期: 2019年12月16日內容資訊: 英文 190 Pages
簡介

全球微射流 (微流體) 市場規模在2019年∼2029年間,預測將以13.73%的年複合成長率 (CAGR) 擴大。

本報告涵括全球微射流 (微流體) 市場,提供市場動態,競爭環境,各市場區隔、各地區的市場,競爭情形,及主要企業等相關的詳細分析。

摘要整理

第1章 調查範圍、手法

第2章 市場概要

  • 市場上可利用的微射流解決方案的特徵
  • 臨床診斷的微射流
  • 全球足跡

第3章 市場動態

  • 概要
  • 影響分析
  • 市場動態
  • 推動市場要素
  • 市場機會

第4章 競爭情形

  • 主要策略、發展

第5章 全球微射流市場:各產品類型

  • 概要
  • 微射流平台
  • 微射流晶片

第6章 全球微射流市場:各用途

  • 概要
  • 照護現場實驗
  • 細胞分析
  • 藥物研發
  • 內臟器官晶片
  • 農業食品產業
  • 微生物研究
  • 其他

第7章 全球微射流市場:各終端用戶

  • 概要
  • 研究、學術研究所
  • 生物醫藥品、生物科技企業
  • 診斷中心
  • 其他終端用戶

第8章 全球微射流市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他 (RoW)

第9章 產業考察

  • 市場佔有率分析
  • 成長佔有率分析

第10章 企業簡介

  • 概要
  • 1CellBio, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Cellix Ltd.
  • Fluidigm Corporation
  • Micronit MicroTechnologies
  • Illumina, Inc.
  • Merck KGaA
  • microfluidic ChipShop GmbH
  • Mission Bio
  • PerkinElemer, Inc.
  • Sphere Fluidics Limited
  • Thermo Fisher Scientific Inc.
  • TaKaRa BIO
  • QIAGEN N.V.
  • uFluidix
目錄
Product Code: BH138A

"Global Microfluidics Market to Grow at a CAGR of 13.73% from 2019-2029."

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global microfluidics market?
  • What are the factors resulting in the emerging trends within the global microfluidics market?
  • How is each segment of the global microfluidics market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global microfluidics market? What are the major segments of these applications?
  • Who are the key manufacturers the global microfluidics products, and what are their contributions?

Global Microfluidics Market Forecast, 2019-2029

The global microfluidics industry analysis by BIS Research projects the market to grow at a significant CAGR of 13.73% during the forecast period, 2019-2029. The microfluidics market generated $10,260.6 million revenue in 2018, in terms of value.

The microfluidics market growth has been primarily attributed to the major drivers in this market such as, growing demand for non-invasive and rapid diagnostics, increase in adoption of personalized medicines on a global level, significant external funding for executing research and development exercises and growing demand for point-of-care testing. The challenges include lack of standardization, a lack of high-complexity testing centers, and high capital requirement hampering the global reach

Expert Quote

"We strongly believe such a technology will help to fill the gaps in existing immunoassay technology and be applied directly to biological samples such as blood, saliva, or urine."

Scope of the Market Intelligence on Microfluidics Market

The microfluidics research provides a holistic view of the market in terms of various factors influencing it, including strategic developments and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the industrial and biological research. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global microfluidics market.

Market Segmentation

The microfluidics market segmentation (on the basis of application) is segmented point-of-care testing, cell analysis, drug development and discovery, organ-on-ac-chip, agro-food industry, microbiological research and other applications.

The microfluidics market segmentation (on the basis of type) is segmented into microfluidic chips and microfluidic platforms.

The microfluidics market segmentation (on the basis of end-user) is segmented into research and academia, biopharmaceutical and biotech companies, diagnostic centers, and other end-users.

The microfluidics market segmentation (on the basis of geography) is segmented into North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World.

Key Companies in the Microfluidics Market

The key manufacturers who have been contributing significantly to the microfluidics market include 1CellBio Inc., Agilent Technologies Inc., Becton, Dickinson and Company, Cellix Ltd., Micronit Microtechnologies, Fluidigm Corporation, Perkin Elmer Inc., microfluidic Chipshop GmbH, Mission Bio, Merck KgaA, Sphere Fluidics, Thermo Fisher Scientific, Inc., Takara Bio Inc., Qiagen N.V. and uFluidix., among others.

Table of Contents

Executive Summary

1 Research Scope and Methodology

  • 1.1 Scope of the Study
  • 1.2 Research Methodology
  • 1.3 Data Sources
  • 1.4 Assumptions and Limitations
  • 1.5 Data and Prediction Modeling

2 Market Overview

  • 2.1 Characteristics of Market Available Microfluidics Solutions
  • 2.2 Microfluidics in Clinical Diagnostics
  • 2.3 Global Footprint

3 Market Dynamics

  • 3.1 Overview
  • 3.2 Impact Analysis
  • 3.3 Market Drivers
    • 3.3.1 Growing Demand for Non-Invasive and Rapid Diagnosis
    • 3.3.2 Increase in Adoption of Personalized Medicine Shifting the Paradigm from Reaction to Prevention on a Global Level
    • 3.3.3 Significant External Funding for Executing Research and Development Exercises
    • 3.3.4 Growing Demand for Point-of-Care Diagnostics
  • 3.4 Market Restraints
    • 3.4.1 Lack of Standardization
    • 3.4.2 Lack of High Complexity Testing Centers
    • 3.4.3 High Capital Requirement Hampering the Expansion of Global Reach
  • 3.5 Market Opportunities
    • 3.5.1 Massive Scope for Adoption of Microfluidics-based Solutions in Emerging Nations
    • 3.5.2 Increased Use of Microfluidics in Widespread Applications
    • 3.5.3 Hybridization of Technologies

4 Competitive Landscape

  • 4.1 Key Strategies and Developments
    • 4.1.1 Synergistic Activities
    • 4.1.2 Funding and Expansion
    • 4.1.3 Product Launches and Upgrades
    • 4.1.4 Mergers and Acquisitions

5 Global Microfluidics Market (by Product Type)

  • 5.1 Overview
  • 5.2 Microfluidic Platforms
  • 5.3 Microfluidic Chips

6 Global Microfluidics Market (by Application)

  • 6.1 Overview
  • 6.2 Point-of-Care Testing
  • 6.3 Cell Analysis
  • 6.4 Drug Development and Discovery
  • 6.5 Organ-on-a-chip
  • 6.6 Agro-Food Industry
  • 6.7 Microbiological Research
  • 6.8 Other

7 Global Microfluidics Market (by End User) 2018-2029

  • 7.1 Overview
  • 7.2 Research and Academic Laboratories
  • 7.3 Biopharmaceutical and Biotech Companies
  • 7.4 Diagnostic Centers
  • 7.5 Other End Users

8 Global Microfluidics Market (by Region)

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest-of-Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Singapore
    • 8.4.6 Rest-of-APAC
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest-of-Latin America
  • 8.6 Rest-of-the-World

9 Industry Insights

  • 9.1 Market Share Analysis
  • 9.2 Growth Share Analysis

10 Company Profiles

  • 10.1 Overview
  • 10.2 1CellBio, Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Role of 1CellBio, Inc. in the Global Microfluidics Market
    • 10.2.3 SWOT Analysis
  • 10.3 Agilent Technologies, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of Agilent Technologies, Inc. in the Global Microfluidics Market
    • 10.3.3 Financials
    • 10.3.4 Key Insights About Financial Health of the Company
    • 10.3.5 SWOT Analysis
  • 10.4 Becton, Dickinson and Company
    • 10.4.1 Company Overview
    • 10.4.2 Role of Becton, Dickinson and Company in the Global Microfluidics Market
    • 10.4.3 Financials
    • 10.4.4 Key Insights About Financial Health of the Company
    • 10.4.5 SWOT Analysis
  • 10.5 Cellix Ltd.
    • 10.5.1 Company Overview
    • 10.5.2 Role of Cellix Ltd. In the Global Microfluidics Market
    • 10.5.3 SWOT Analysis
  • 10.6 Fluidigm Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Role of Fluidigm Corporation in the Global Microfluidics Market
    • 10.6.3 Financials
    • 10.6.4 Key Insights About Financial Health of the Company
    • 10.6.5 SWOT Analysis
  • 10.7 Micronit MicroTechnologies
    • 10.7.1 Company Overview
    • 10.7.2 Role of Micronit MicroTechnologies in the Global Microfluidics Market
    • 10.7.3 SWOT Analysis
  • 10.8 Illumina, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Role of Illumina, Inc. in the Global Microfluidics Market
    • 10.8.3 Financials
    • 10.8.4 Key Insights About Financial Health of the Company
    • 10.8.5 SWOT Analysis
  • 10.9 Merck KGaA
    • 10.9.1 Company Overview
    • 10.9.2 Role of Merck KGaA in the Global Microfluidics Market
    • 10.9.3 Financials
    • 10.9.4 Key Insights About Financial Health of the Company
    • 10.9.5 SWOT Analysis
  • 10.10 microfluidic ChipShop GmbH
    • 10.10.1 Company Overview
    • 10.10.2 Role of microfluidic ChipShop GmbH in the Global Microfluidics Market
    • 10.10.3 SWOT Analysis
  • 10.11 Mission Bio
    • 10.11.1 Company Overview
    • 10.11.2 Role of Mission Bio in the Global Microfluidics Market
    • 10.11.3 SWOT Analysis
  • 10.12 PerkinElemer, Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Role of PerkinElemer, Inc.in the Global Microfluidics Market
    • 10.12.3 Financials
    • 10.12.4 Key Insights About Financial Health of the Company
    • 10.12.5 SWOT Analysis
  • 10.13 Sphere Fluidics Limited
    • 10.13.1 Company Overview
    • 10.13.2 Role of Sphere Fluidics Limited in the Global Microfluidics Market
    • 10.13.3 SWOT Analysis
  • 10.14 Thermo Fisher Scientific Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Role of Thermo Fisher Scientific in the Global Microfluidics Market
    • 10.14.3 Financials
    • 10.14.4 Key Insights About Financial Health of the Company
    • 10.14.5 SWOT Analysis
  • 10.15 Takara Bio Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Role of Takara Bio Inc. in the Global Microfluidics Market
    • 10.15.3 Financials
    • 10.15.4 Key Insights About Financial Health of the Company
    • 10.15.5 SWOT Analysis
  • 10.16 QIAGEN N.V.
    • 10.16.1 Company Overview
    • 10.16.2 Role of QIAGEN N.V. in the Global Microfluidics Market
    • 10.16.3 Financials
    • 10.16.4 Key Insights About Financial Health of the Company
    • 10.16.5 SWOT Analysis
  • 10.17 uFluidix
    • 10.17.1 Company Overview
    • 10.17.2 Role of uFluidix in the Global Microfluidics Market
    • 10.17.3 SWOT Analysis

List of Tables

  • Table 2.1: Market Available Microfluidics Products
  • Table 3.1: Impact Analysis of Market Drivers
  • Table 3.2: Impact Analysis of Market Restraints

List of Figures

  • Figure 1: Impact of Market Drivers and Market Restraints on the Global Microfluidics Market
  • Figure 2: Global Microfluidics Market Snapshot, 2018 and 2029
  • Figure 3: Dominating Segments of the Global Microfluidics Market, 2018 and 2029
  • Figure 4: Key Strategies Incorporated by Stakeholders of Microfluidics Market to Sustain the Competition (from 2016 to 2019)
  • Figure 5: Global Microfluidics Market (by Product), 2018 and 2029
  • Figure 6: Global Microfluidics Market (by End User), 2018 and 2029
  • Figure 7: Global Microfluidics Market (by Region) 2018 and 2029
  • Figure 1.1: Global Microfluidics Market Segmentation
  • Figure 1.2: Global Microfluidics Market Research Methodology
  • Figure 1.3: Primary Research
  • Figure 1.4: Secondary Research
  • Figure 1.5: Data Triangulation
  • Figure 1.6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 1.7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 1.8: Assumptions and Limitations
  • Figure 1.9: Considered Factors for Data Prediction and Modeling
  • Figure 2.1: Characteristics of Commercially Available Microfluidics Products
  • Figure 2.2: Global Microfluidics Market, 2018-2029 ($Million)
  • Figure 4.1: Share of Key Developments and Strategies, 2016-2019
  • Figure 4.2: Synergistic Activities Share (by Company), 2016 - 2019
  • Figure 4.3: Funding and Expansion Share (by Company), 2016 -2019
  • Figure 4.4: Product Launches and Upgrades Share (by Company), 2016-2019
  • Figure 4.5: Mergers and Acquisitions Share (by Company), 2016-2019
  • Figure 5.1: Global Microfluidics Market (by Product Type)
  • Figure 5.2: Global Microfluidics (by Product Type), 2018 and 2029
  • Figure 5.3: Global Microfluidic Platforms Market, 2018-2029 ($Million)
  • Figure 5.4: Global Microfluidic Chips Market, 2018-2029 ($Million)
  • Figure 6.1: Global Microfluidics Market (by Application), 2018-2029 ($Million)
  • Figure 6.2: Global Microfluidics Market (Point-of-Care Testing), 2018-2029 ($Million)
  • Figure 6.3: Global Microfluidics Market (By Cell Analysis), 2018-2029 ($Million)
  • Figure 6.4: Global Microfluidics Market (By Drug Development and Discovery), 2018-2029 ($Million)
  • Figure 6.5: Global Microfluidics Market (By Organ-on-a-chip), 2018-2029 ($Million)
  • Figure 6.6: Global Microfluidics Market (By Agro-food Industry), 2018-2029 ($Million)
  • Figure 6.7: Global Microfluidics Market (By Microbiological Industry), 2018-2029 ($Million)
  • Figure 6.8: Global Microfluidics Market (by Other Applications), 2018-2029 ($Million)
  • Figure 7.1: Global Microfluidics Market (by End User)
  • Figure 7.2: Global Microfluidics Market (by End User), 2018-2029 ($Million)
  • Figure 7.3: Global Microfluidics Market (by Biopharmaceutical and Biotech companies), 2018-2029 ($Million)
  • Figure 7.4: Global Microfluidics Market (Diagnostic Centres), 2018-2029 ($Million)
  • Figure 7.5: Global Microfluidics Market (by Other End-User), 2018-2029 ($Million)
  • Figure 8.1: Global Microfluidics Market (by Region), 2018 and 2029 ($Million)
  • Figure 8.2: Global Microfluidics Market (by Region), 2018-2029 ($Million)
  • Figure 8.3: Global Microfluidics Market Share (by Region), 2018 ($Million)
  • Figure 8.4: Global Microfluidics Market Share (by Region), 2029 ($Million)
  • Figure 8.5: North America Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.6: North America Microfluidics Market (by Country), 2018-2029 ($Million)
  • Figure 8.7: North America: Market Dynamics
  • Figure 8.8: The U.S. Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.9: Canada Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.10: Europe Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.11: Europe: Market Dynamics
  • Figure 8.12: Europe Microfluidics Market (by Country), 2018-2029 ($Million)
  • Figure 8.13: Germany Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.14: U.K. Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.15: France Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.16: Italy Microfluidics Market, 2018-2029 ($Million)
  • Figure 8 17: Spain Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.18: Rest-of-Europe Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.19: Asia-Pacific Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.20: APAC: Market Dynamics
  • Figure 8.21: APAC Global Microfluidics Market (by Country), 2018-2029 ($Million)
  • Figure 8.22: China Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.23: Japan Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.24: India Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.25: Australia Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.26: Singapore Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.27: RoAPAC Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.28: Latin America Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.29: Latin America: Market Dynamics
  • Figure 8.30: Latin America Microfluidics Market (by Country), 2018-2029 ($Million)
  • Figure 8.31: Brazil Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.32: Mexico Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.33: Rest-of-Latin America Microfluidics Market, 2018-2029 ($Million)
  • Figure 8.34: RoW Microfluidics Market, 2018-2029 ($Million)
  • Figure 9.1: Market Share Analysis for the Global Microfluidics Market, 2018
  • Figure 9.2: Growth Share Matrix for Microfluidics Market (by Company), 2018
  • Figure 10.1: Total Number of Companies Profiled
  • Figure 10.2: 1CellBio, Inc.: Overall Product Portfolio
  • Figure 10.3: 1CellBio, Inc.: SWOT Analysis
  • Figure 10.4: Agilent Technologies, Inc.: Overall Product Portfolio
  • Figure 10.5: Agilent Technologies, Inc.: Overall Financials, 2016-2018
  • Figure 10.6: Agilent Technologies, Inc.: Revenue (by Segment), 2016-2018
  • Figure 10.7: Agilent Technologies, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.8: Agilent Technologies, Inc.: R&D Expenditure, 2016-2018
  • Figure 10.9: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 10.10: Beckton, Dickinson and Company: Overall Product Portfolio
  • Figure 10.11: Becton, Dickinson and Company: Overall Financials, 2016-2018
  • Figure 10.12: Becton, Dickinson and Company: Revenue (by Business Segment), 2016-2018
  • Figure 10.13: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2016-2018
  • Figure 10.14: Becton, Dickinson and Company: Revenue (by Region), 2016-2018
  • Figure 10.15: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
  • Figure 10.16: Becton, Dickinson and Company: SWOT Analysis
  • Figure 10.17: Cellix Ltd.: Overall Product Portfolio
  • Figure 10.18: Cellix Ltd.: SWOT Analysis
  • Figure 10.19: Fluidigm Corporation: Overall Product Portfolio
  • Figure 10.20: Fluidigm Corporation: Overall Financials, 2016-2018
  • Figure 10.21: Fluidigm Corporation: Revenue (by Segment), 2016-2018
  • Figure 10.22: Fluidigm Corporation: Revenue (by Region), 2016-2018
  • Figure 10.23: Fluidigm Corporation: R&D Expenditure, 2016-2018
  • Figure 10.24: Fluidigm Corporation: SWOT Analysis
  • Figure 10.25: Micronit Micro Technologies: Overall Product Portfolio
  • Figure 10.26: Micronit Micro Technologies: SWOT Analysis
  • Figure 10.27: Illumina, Inc.: Overall Product Portfolio
  • Figure 10.28: Illumina, Inc.: Overall Financials, 2016-2018
  • Figure 10.29: Illumina, Inc.: Revenue (by Segment), 2016-2018
  • Figure 10.30: Illumina, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.31: Illumina, Inc.: R&D Expenditure, 2016-2018
  • Figure 10.32: Illumina, Inc.: SWOT Analysis
  • Figure 10.33: Merck KGaA: Overall Product Portfolio
  • Figure 10.34: Merck KGaA: Overall Financials, 2016-2018
  • Figure 10.35: Merck KGaA: Revenue (by Segment), 2016-2018
  • Figure 10.36: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 10.37: Merck KGaA: R&D Expenditure, 2016-2018
  • Figure 10.38: Merck KGaA: SWOT Analysis
  • Figure 10.39: microfluidic ChipShop GmbH: Overall Product Portfolio
  • Figure 10.40: microfluidic ChipShop GmbH: SWOT Analysis
  • Figure 10.41: Mission Bio: Overall Product Portfolio
  • Figure 10.42: Mission Bio: SWOT Analysis
  • Figure 10.43: PerkinElmer, Inc.: Overall Product Portfolio
  • Figure 10.44: PerkinElmer, Inc.: Overall Financials, 2016-2018
  • Figure 10.45: PerkinElmer, Inc.: Sales (by Segment), 2016-2018
  • Figure 10.46: PerkinElmer, Inc.: Sales (by Region), 2016-2018
  • Figure 10.47: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
  • Figure 10.48: PerkinElmer, Inc.: SWOT Analysis
  • Figure 10.49: Sphere Fluidics Limited: Overall Product Portfolio
  • Figure 10.50: Sphere Fluidics Limited: SWOT Analysis
  • Figure 10.51: Thermo Fisher Scientific Inc.: Overall Product Portfolio
  • Figure 10.52: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 10.53: Thermo Fisher Scientific Inc: Sales (by Segment), 2016-2018
  • Figure 10.54: Thermo Fisher Scientific Inc.: Sales (by Region), 2016-2018
  • Figure 10.55: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 10.56: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 10.57: Takara Bio Inc.: Overall Product Portfolio
  • Figure 10.58: Takara Bio Inc.: Overall Financials, 2016-2018
  • Figure 10.59: Takara Bio Inc.: Revenue (by Segment), 2016-2018
  • Figure 10.60: Takara Bio Inc.: Revenue (by Region), 2016-2018
  • Figure 10.61: Takara Bio Inc.: R&D Expenditure, 2016-2018
  • Figure 10.62: Takara Bio Inc.: SWOT Analysis
  • Figure 10.63: QIAGEN N.V.: Overall Product Portfolio
  • Figure 10.64: QIAGEN N.V.: Overall Financials, 2016-2018
  • Figure 10.65: QIAGEN N.V.: Revenue (by Segment), 2016-2018
  • Figure 10.66: QIAGEN N.V.: Revenue (by Region), 2016-2018
  • Figure 10.67: QIAGEN N.V.: R&D Expenditure, 2016-2018
  • Figure 10.68: QIAGEN N.V.: SWOT Analysis
  • Figure 10.69: uFluidix: Overall Product Portfolio
  • Figure 10.70: uFluidix: SWOT Analysis
Back to Top